Gene · 2213
NIH grants2,625
NIH grants whose papers are about the gene, through NIH's grant-paper links.
641 to 660 of 2,625
Download this page as JSON| Grant | Title | FCGR2B papers | Newest fiscal year |
|---|---|---|---|
| R01AG062383 | Sialic Acid Modulation of HIV-associated Chronic Inflammaging | 2 | 2023 |
| R01AI073148 | Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies | 2 | 2023 |
| R01AI145045 | Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action | 2 | 2023 |
| R01AI153098 | Triggering germline-encoded broadly neutralizing antibody responses against influenza virus | 2 | 2023 |
| R01CA177909 | Platelets promote growth of ovarian cancer | 2 | 2023 |
| R01NS117458 | Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression | 2 | 2023 |
| R21AI170166 | Single-cell Analysis of Glycomic and Proteomic Features of the HIV Reservoir | 2 | 2023 |
| R25GM055336 | UNC Initiative for Maximizing Student Development | 2 | 2023 |
| T32CA009111 | Viral Oncology Training Grant | 2 | 2023 |
| T32GM007276 | Cellular and Molecular Biology Training Program | 2 | 2023 |
| T32GM007739 | Weill Cornell/Rockefeller/Sloan Kettering MST Program | 2 | 2023 |
| ZIAAI001221 | Clinical and translational evaluation of vaccination strategies for Zika, Chikungunya, Dengue, Leishmania, Malaria, and other important or emerging vector-borne diseases | 2 | 2023 |
| F30AI160909 | Follicular helper T cells as drivers of epitope spreading | 1 | 2023 |
| I01BX004525 | Engineering of broadly reactive seroantibodies | 1 | 2023 |
| I01BX005448 | B-cell innate and adaptive protective immunity to SARS-CoV-2 | 1 | 2023 |
| K01HL140804 | The impact of the HIV reservoir on pulmonary myeloid cells: virology, phenotype, and function | 1 | 2023 |
| K08CA230157 | Role of tumor burden in limiting durable reinvigoration by PD-1 blockade | 1 | 2023 |
| K23AI141694 | Cellular and Molecular Mechanisms of the Pathogenesis of Aspirin Exacerbated Respiratory Disease | 1 | 2023 |
| K23AI144036 | Temporal dynamics of MDRO eradication after FMT | 1 | 2023 |
| K23DK111995 | Assessing Predictors of Response to Anti-Tumor Necrosis Alpha Therapy in Early Crohns Disease | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/grants?page=33